Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Karsten Spiekermann

MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML

Cell Reports

English

Isolated Trisomy 13 Defines a Homogeneous AML Subgroup With High Frequency of Mutations in Spliceosome Genes and Poor Prognosis

English

Persistence of Pre-Leukemic Clones During First Remission and Risk of Relapse in Acute Myeloid Leukemia

English

The Clinical Mutatome of Core Binding Factor Leukemia

English

Toll‐like Receptor 7/8‐matured RNA‐transduced Dendritic Cells as Post‐remission Therapy in Acute Myeloid Leukaemia: Results of a Phase I Trial

Clinical and Translational Immunology

English

Genetics of Acute Myeloid Leukemia in the Elderly: Mutation Spectrum and Clinical Impact in Intensively Treated Patients Aged ≥ 75 Years

Haematologica

Hematology

2018

English

T-Cell-Replete HLA-Haploidentical Transplantation Using Post-Transplantation High-Dose Cyclophosphamide in High Risk and Advanced ALL: Feasibility and Early Outcome

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Mediation Analysis Reveals Common Mechanisms of RUNX1 Point Mutations and RUNX1/RUNX1T1 Fusions Influencing Survival of Patients With Acute Myeloid Leukemia

Scientific Reports

Multidisciplinary

2018

English

The AML1-ETO Fusion Gene and the FLT3 Length Mutation Collaborate in Inducing Acute Leukemia in Mice

Journal of Clinical Investigation

Medicine

2005

English

Overexpression of CDX2 Perturbs HOX Gene Expression in Murine Progenitors Depending on Its N-Terminal Domain and Is Closely Correlated With Deregulated HOX Gene Expression in Human Acute Myeloid Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Karsten Spiekermann

MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML

Isolated Trisomy 13 Defines a Homogeneous AML Subgroup With High Frequency of Mutations in Spliceosome Genes and Poor Prognosis

Persistence of Pre-Leukemic Clones During First Remission and Risk of Relapse in Acute Myeloid Leukemia

The Clinical Mutatome of Core Binding Factor Leukemia

Toll‐like Receptor 7/8‐matured RNA‐transduced Dendritic Cells as Post‐remission Therapy in Acute Myeloid Leukaemia: Results of a Phase I Trial

Genetics of Acute Myeloid Leukemia in the Elderly: Mutation Spectrum and Clinical Impact in Intensively Treated Patients Aged ≥ 75 Years

T-Cell-Replete HLA-Haploidentical Transplantation Using Post-Transplantation High-Dose Cyclophosphamide in High Risk and Advanced ALL: Feasibility and Early Outcome

Mediation Analysis Reveals Common Mechanisms of RUNX1 Point Mutations and RUNX1/RUNX1T1 Fusions Influencing Survival of Patients With Acute Myeloid Leukemia

The AML1-ETO Fusion Gene and the FLT3 Length Mutation Collaborate in Inducing Acute Leukemia in Mice

Overexpression of CDX2 Perturbs HOX Gene Expression in Murine Progenitors Depending on Its N-Terminal Domain and Is Closely Correlated With Deregulated HOX Gene Expression in Human Acute Myeloid Leukemia